By Counterforce Health Team in Elaprase (idursulfase) —

How to Get Elaprase (Idursulfase) Covered by Blue Cross Blue Shield in North Carolina: Prior Authorization, Appeals, and Financial Assistance

Answer Box: Getting Elaprase Covered in North Carolina

Elaprase (idursulfase) requires prior authorization under Blue Cross Blue Shield of North Carolina as a Tier 5 specialty drug. To get coverage: (1) Your doctor submits a PA request with confirmed Hunter syndrome diagnosis and weight-based dosing through Prime Therapeutics portal, (2) Use BCBSNC's specialty pharmacy network for fills, and (3) If denied, appeal within 180 days via internal review, then external review through Smart NC if needed. Start by checking your coverage at bluecrossnc.com/drug-search.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Doctor must get approval before prescribing Required for all Tier 5 specialty drugs BCBSNC NetResults Formulary
Formulary Tier Tier 5 specialty drug (highest cost-sharing) Check drug search tool BCBSNC Drug Search
Specialty Pharmacy Must use network specialty pharmacy Required for all specialty medications BCBSNC Specialty Network
Medical Necessity Confirmed Hunter syndrome diagnosis required Enzyme assay or genetic testing Prime Therapeutics PA Portal
Appeals Deadline 180 days from denial date Standard for commercial plans Smart NC External Review

Step-by-Step: Fastest Path to Approval

1. Confirm Your Coverage (Patient)

Check if Elaprase is covered under your specific BCBSNC plan using their online drug search tool. Enter "Elaprase" or "idursulfase" to see tier status and PA requirements.

Timeline: 5 minutes
What you'll need: Member ID from insurance card

2. Gather Required Documentation (Clinic)

Your healthcare provider needs to collect:

  • Confirmed Hunter syndrome diagnosis (enzyme assay or genetic testing results)
  • Patient weight for dosing calculations
  • Previous treatment history (if applicable)
  • Clinical notes supporting medical necessity

Timeline: 1-2 business days
Tip: Request these records early if transferring from another provider.

3. Submit Prior Authorization (Provider)

Provider submits PA request through Prime Therapeutics portal or by fax with required clinical documentation.

Timeline: Same day submission
What happens next: BCBSNC has up to 15 days for standard review, 72 hours for expedited

4. Transfer to Specialty Pharmacy (Patient)

Once approved, transfer prescription to a BCBSNC network specialty pharmacy such as:

  • Accredo Health: 877-261-5596
  • FirstHealth: 855-715-7939
  • Novant Health: 855-307-6868

Timeline: 2-4 business days for setup

Prior Authorization Process

Blue Cross Blue Shield of North Carolina requires prior authorization for Elaprase because it's classified as a specialty medication. The process is managed through Prime Therapeutics, BCBSNC's pharmacy benefit manager.

Required Clinical Documentation

Your doctor must provide evidence of:

  • Confirmed Hunter syndrome diagnosis via enzyme assay showing iduronate-2-sulfatase deficiency or genetic testing
  • Patient weight for accurate dosing calculations (0.5 mg/kg weekly)
  • Medical necessity demonstrating why Elaprase is appropriate for your specific case
  • Infusion monitoring plan for managing potential infusion reactions
Clinician Corner: The medical necessity letter should reference FDA labeling for Elaprase and include specific ICD-10 codes (E76.1 for mucopolysaccharidosis II). Include baseline assessments like liver/spleen size, joint range of motion, and pulmonary function if available.

Submission Methods

Providers can submit PA requests via:

  • Online: Prime Therapeutics portal (preferred method)
  • Fax: Check denial letter for plan-specific fax number
  • Phone: 24-hour contact center at 888-274-5186

Review Timeline: 15 days for standard requests, 72 hours for expedited reviews when urgent medical need is documented.

Specialty Pharmacy Network Requirements

BCBSNC mandates that all specialty medications, including Elaprase, must be obtained through their designated specialty pharmacy network for coverage. This requirement ensures proper handling, storage, and patient support for complex medications.

Network Specialty Pharmacies

Pharmacy Phone Services
Accredo Health 877-261-5596 24/7 nursing support, home delivery
FirstHealth 855-715-7939 Regional coverage, infusion coordination
HPC Specialty Pharmacy 800-757-9192 Disease-specific monitoring
Novant Health 855-307-6868 Integrated health system pharmacy
Onco360 877-662-6633 Specialty drug expertise
Note: Using non-network pharmacies may result in higher out-of-pocket costs or no coverage. Always verify network status before filling prescriptions.

For provider-administered infusions, BCBSNC's Office-Administered Specialty Pharmacy Network delivers medications directly to covered infusion centers, with the pharmacy billing BCBSNC directly.

Appeals Process for Denials

If your Elaprase prior authorization is denied, North Carolina offers strong appeal rights through both internal insurance company reviews and external state oversight.

Internal Appeals (First Step)

Timeline: Must file within 180 days of denial
Review period: 30 days for standard, 72 hours for expedited
How to file: Use BCBSNC's online portal, fax, or certified mail

Required documentation:

  • Original denial letter with claim number
  • Medical records supporting Hunter syndrome diagnosis
  • Clinical evidence of medical necessity
  • Prescriber statement addressing specific denial reasons

External Review (Second Step)

If your internal appeal is denied, you can request external review through North Carolina's Smart NC program within 120 days.

Contact Smart NC:

Process:

  1. Submit external review request form
  2. Smart NC assigns Independent Review Organization (IRO)
  3. IRO reviews case within 45 days (72 hours for expedited)
  4. Decision is binding on BCBSNC
From our advocates: We've seen Hunter syndrome families succeed in external review by emphasizing that Elaprase is the only FDA-approved enzyme replacement therapy for MPS II, making it irreplaceable when medically necessary. The key is demonstrating that denial would leave the patient without any equivalent treatment option.

Financial Assistance Programs

Even with insurance coverage, Elaprase's high cost can create significant financial burden. Several assistance programs can help North Carolina families manage these expenses.

Takeda Patient Support Program

Takeda offers comprehensive support for commercially insured patients:

  • Co-Pay Assistance: Can reduce out-of-pocket costs to as little as $5 per dose
  • Benefits Investigation: Specialists help navigate insurance requirements
  • Prior Authorization Support: Assistance with PA submissions and appeals

Eligibility: Commercial insurance required
Contact: 866-888-0660
Website: Takeda Patient Support

NORD Financial Assistance

The National Organization for Rare Disorders provides several programs for Hunter syndrome patients in North Carolina:

Premium Copay Program: Covers insurance premiums, deductibles, and copays
Medical Assistance Program: Funds out-of-pocket medical expenses for uninsured/underinsured patients
Diagnostic Testing Program: Assists with diagnostic costs

Contact NORD:

Help At Hand Program

For patients without adequate commercial insurance, Takeda's Help At Hand program provides free medication to eligible patients who meet financial criteria.

Website: Help At Hand

Common Denial Reasons & Solutions

Denial Reason How to Overturn
Missing genetic/enzyme confirmation Submit enzyme assay results or genetic testing showing iduronate-2-sulfatase deficiency
Lack of infusion monitoring plan Provide detailed plan for managing infusion reactions, including premedication protocols
Use outside labeled population Reference FDA labeling confirming approval for pediatric and adult MPS II patients
Quantity limits exceeded Submit weight-based dosing calculations (0.5 mg/kg weekly) with current patient weight
Step therapy requirement Document that no FDA-approved alternatives exist for Hunter syndrome

When to Request External Review

Consider external review through Smart NC if:

  • Internal appeals are denied despite strong medical evidence
  • BCBSNC fails to respond within required timeframes
  • You believe the denial violates North Carolina insurance laws
  • Clinical guidelines clearly support Elaprase use for your situation

External review is particularly effective for rare disease medications like Elaprase because Independent Review Organizations often have specialized medical expertise and aren't bound by insurance company policies.

Success factors:

  • Comprehensive medical records
  • Clear documentation of Hunter syndrome diagnosis
  • Evidence that Elaprase is medically necessary and has no alternatives
  • Support from treating specialists familiar with MPS II

FAQ

How long does BCBSNC prior authorization take?
Standard PA reviews take up to 15 days. Expedited reviews (when urgent medical need is documented) are completed within 72 hours.

What if Elaprase is non-formulary on my plan?
You can request a formulary exception by demonstrating medical necessity and that no covered alternatives are appropriate for Hunter syndrome treatment.

Can I request an expedited appeal?
Yes, if delaying treatment would seriously jeopardize your health. Mark "expedited" on appeal forms and provide supporting clinical documentation.

Does step therapy apply to Elaprase?
Rarely, since no FDA-approved alternatives exist for Hunter syndrome. If required, document the unique nature of MPS II and lack of therapeutic alternatives.

What happens if I miss the 180-day appeal deadline?
Contact BCBSNC immediately to request an exception. Document any extenuating circumstances that prevented timely filing.

Can Smart NC help with my appeal?
Yes, Smart NC provides free advocacy and can help you prepare your external review request. Call 855-408-1212 for assistance.

Do I need a specialist to prescribe Elaprase?
While not always required, having a geneticist, metabolic specialist, or pediatric specialist involved strengthens your case for medical necessity.

How often do I need reauthorization?
Most plans require annual reauthorization. BCBSNC will notify you before your current authorization expires.

About Counterforce Health: Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Our platform helps patients and providers navigate complex prior authorization requirements and appeals processes for specialty medications like Elaprase.

For additional support with your Elaprase coverage journey, Counterforce Health offers tools and expertise specifically designed to help families secure coverage for rare disease treatments through strategic appeals and comprehensive documentation.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with Blue Cross Blue Shield of North Carolina and consult with your healthcare provider about treatment decisions. For personalized assistance with North Carolina insurance appeals, contact Smart NC at 855-408-1212.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.